Allostatic load in women with infertility: a cross-sectional analysis study from NHANES 2015–2018 Authors: Shiyin Mu Published: 2025 ABSTRACT BackgroundInfertility affects approximately 15% of couples globally and is recognized as a major public health concern. Infertile women often experience significant psychological stress due to various factors, including work-related pressures, family dynamics, and reproductive challenges. However, the role of allostatic load—a marker of chronic stress and physiological dysregulation—in infertile women has been scarcely investigated.PurposeThis study aimed to explore the association between allostatic load and infertility, as well as to identify potential biomarkers that can predict allostatic load in infertile women.MethodThe study included 419 participants from the 2015–2018 National Health and Nutrition Examination Survey (NHANES), comprising 59 individuals with infertility and 360 controls. Allostatic load was assessed using a composite of biomarkers, including diastolic blood pressure (DBP), systolic blood pressure (SBP), body mass index (BMI), abdomen circumference (AC), homeostatic model assessment of insulin resistance (HOMA-IR), triglycerides (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and high-sensitivity C-reactive protein (hs-CRP). Data analysis was performed using R (R Core Team, 2021) and IBM SPSS Statistics 22.0, with statistical significance set at P < 0.05.ResultWomen with infertility had significantly higher AC, BMI, and SBP, but lower HDL levels compared with controls (all p < 0.05), after weighting, the differences between the two groups in AC, BMI, and HDL remained statistically significant (P = 0.021, 0.035, 0.024. respectively). The allostatic load score was also significantly higher in the infertility group (p = 0.011), after weighting, this difference remained statistically significant (P = 0.029). Subgroup analysis suggested a stronger association between allostatic load and infertility among non-smoking women. BMI, LDL, TG, HDL, and hs-CRP were identified as key biomarkers predictive of allostatic load in infertile women.ConclusionAllostatic load was significantly higher in infertile women, highlighting the importance of assessing allostatic load in clinical management, particularly among non-smoking women. BMI, LDL, TG, HDL, and hs-CRP were identified as key biomarkers associated with allostatic load in this population. Introduction Infertility, defined as the inability to conceive after 12 months of regular unprotected intercourse, affects approximately 15% of couples worldwide and remains a significant public health and psychosocial concern, particularly for women [1, 2] Chronic or repeated stress exerts profound effects on multiple physiological systems, including the nervous, endocrine, and immune systems, and has been implicated in the pathogenesis of various diseases [3–5]. Growing evidence also suggests a potential link between stress and female infertility [6, 7]. While the human body can adapt to short-term or acute stress responses, prolonged or repeated exposure to stressors—such as those arising from work, family, or reproductive challenges—can lead to dysregulation across these systems. This cumulative burden is termed allostatic load (AL), a concept that reflects the wear and tear on the body due to chronic stress [8]. Previous studies have explored the relationship between AL and reproductive outcomes. For example, Barrett et al. reported that higher AL was associated with adverse pregnancy outcomes, although it did not appear to influence fertility in women with unexplained infertility [9]. In a Chinese cohort, Xiang et al. found that women with higher allostatic load scores (ALS) tended to have lower fertility [10]. Women of reproductive age often face chronic stress related to family responsibilities, professional demands, and societal expectations surrounding childbirth—factors that are frequently overlooked but may contribute to reproductive challenges. To our knowledge, the aforementioned studies represent the only two that have investigated the relationship between AL and infertility, yielding somewhat differing results and focusing on specific populations. In this study, we aimed to evaluate the association between allostatic load and female infertility by comparing ALS between infertile and fertile women. Our objective was to provide new insights into the role of chronic stress in infertility and to offer evidence-based considerations for clinicians managing women with infertility. Materials and methods Study design and population This study used data from the 2015 to 2018 cycles of the NHANES, a nationwide cross-sectional survey that employed a multistage, stratified, probability sampling design. These cycles were selected because key variables, including measures of allostatic load and infertility status, were consistently available during this period. A total of 19,225 participants were initially identified. Participants were excluded for the following reasons: (1) male sex (n = 9,449); (2) current pregnancy or unknown pregnancy status (n = 7,685); (3) unmarried or living alone (i.e., not in a marital or cohabiting relationship) (n = 896); (4) missing data for the reproductive health questionnaire item (RHQ074) (n = 212); and (5) missing biomarker data for > 25% of the selected variables (n = 564).After applying these exclusion criteria, the final analytic sample comprised 419 participants, including 59 women with infertility and 360 women without infertility (Fig. 1).Fig. 1Flowchart showing the selection of the studied population Flowchart showing the selection of the studied population Laboratory methods Serum samples were obtained from participants after an overnight fast of at least 9 h. These samples were stored at − 30 °C prior to being transported to the Centers for Disease Control and Prevention/National Center for Environmental Health/Laboratory Science Division (CDC/NCEH/DLS) for analysis. The serum concentrations of HDL, LDL, and TGwere determined using a Cobas 6000 Chemistry Analyzer. The hs-CRP level was measured using the Roche Cobas 6000 (c501 module). All these assays were carried out by the Advanced Research and Diagnostic Laboratory (ARDL) at the University of Minnesota, located at 1200 Washington Ave S, Suite 175, Minneapolis, MN 55415.The serum levels of insulin and glucose were measured using the Tosoh Bioscience AIA—900 and the Roche/Hitachi Cobas C Chemistry Analyzer—C311, respectively. These measurements were performed by the Diabetes Diagnostic Laboratory at the University of Missouri, situated at 1 Hospital Dr, Columbia, MO 65212. Allostatic load calculation Allostatic load was quantified by aggregating standardized biomarkers of metabolic, immune and cardiovascular dysregulation, including diastolic and systolic blood pressure, BMI, AC, HOMA-IR, TG, LDL-C, HDL, and hs-CRP. HOMA-IR was derived from fasting insulin (μU/mL) and fasting glucose (mmol/L) using the formula: fasting insulin × fasting glucose/22.5 [11] ALS was calculated by turning each biomarker into a dichotomous variable with 1 point given if the biomarker was in the high-risk range and 0 if not. The population was divided into quartiles and high risk was defined as greater than the 75th percentile for all variables except for HDL [11] Participants receiving antihypertensive or lipid-lowering medications were assigned a half-point (0.5) for the respective biomarkers (blood pressure or lipids), regardless of their measured values. The allostatic load score was computed as the sum of individual biomarker scores, yielding a composite range of 0–10. Definition of infertility In this study, infertility was defined as the inability to achieve pregnancy after 12 months or more of regular, unprotected sexual intercourse. Covariates The selection of covariates was based on prior evidence and clinical relevance. Demographic characteristics—including age, race, educational attainment, and annual household income—were ascertained through standardized household interviews. Demographic characteristics—including age, race, educational attainment, and annual household income—were ascertained through standardized household interviews. Race was categorized as Hispanic, non-Hispanic, and other races. Educational level was classified as below or equal to high school, college and graduate degree. Annual household income was grouped into three categories: less than $45,000, $45,000–$100,000, and more than $100,000. In addition, daily smoking intake was also included as a covariate. Statistical analysis We conducted weighted analyses using the sample weights (WTSAF2YR) provided by the NHANES database to account for the complex survey design and ensure national representative. All statistical analyses were performed using R Core Team (2021) and SPSS software (version 22; Armonk, NY: IBM Corp.). Descriptive statistics were employed to characterize baseline participant demographics. The Kolmogorov–Smirnov test was used to assess data normality. For continuous variables, normally distributed data were analyzed using Student’s t-test and reported as mean ± standard deviation (SD), non-normally distributed data were analyzed using the Mann–Whitney U test and reported as median (interquartile range: Q3–Q1). Categorical variables were expressed as frequencies (n) and percentages (%) and compared using the chi-square test. Logistic regression model was used to evaluate the association between the allostatic load and infertility, and the strength of the association was quantified using odds ratios (ORs) with 95% confidence intervals (CIs). Model robustness was assessed through three progressively adjusted models: Model 1: Unadjusted (reproductive history only). Model 2: Adjusted for age, race, educational attainment, and annual household income (in addition to Model 1 variables). Model 3: Further adjusted for smoking consumption (building upon Model 2). All tests were two-tailed, with statistical significance defined as P < 0.05. Results Baseline characteristics of participants by allostatic load index and infertility status. The demographic and clinical characteristics of study participants are presented in Table 1. No statistically significant differences were observed between the infertility group and control group regarding age (P = 0.307), race (P = 0.838), annual household income (P = 0.595), or educational attainment (P = 0.538), after weighting, the conclusions remained consistent. However, a significantly higher proportion of current smokers was observed in the infertility group compared to controls (38.98% vs. 25.80%, P = 0.036), after weighting, there was no significant difference between the two groups (P = 0.211). Table 1Baseline characteristics of participantsCharacteristicOverall (n = 419)Infertility group (n = 59)Control group (n = 360)P-valueWeighted p-valueAge(x ± s)33.05 ± 6.7033.88 ± 6.9032.92 ± 6.660.307a0.295Race(N,%) Hispanic145(34.61)19(32.20)126(35.00) Non-Hispanic184(43.91)28(47.46)156(43.33)0.838b0.771 Other races90(21.48)12(20.34)78(21.67)Income (N, %) < 45000 dollar167(39.86)20(33.90)147(40.83) 45000–100000 dollar172(41.05)27(45.76)145(40.28)0.595b0.678 > 100000 dollar80(19.09)12(20.34)68(18.89)Education (N, %) High school graduate or less153(36.51)19(32.20)134(37.22) College144(34.37)24(40.68)120(33.33)0.538b0.678 Graduate degree122(29.12)16(27.12)106(29.45)Smoke (N, %) Yes106(27.68)23(38.98)93(25.80) No303(72.32)36(61.02)267(74.72)0.036*b0.211aindependent-samples t-testbchi-square test*p < 0.05 Table 1Baseline characteristics of participantsCharacteristicOverall (n = 419)Infertility group (n = 59)Control group (n = 360)P-valueWeighted p-valueAge(x ± s)33.05 ± 6.7033.88 ± 6.9032.92 ± 6.660.307a0.295Race(N,%) Hispanic145(34.61)19(32.20)126(35.00) Non-Hispanic184(43.91)28(47.46)156(43.33)0.838b0.771 Other races90(21.48)12(20.34)78(21.67)Income (N, %) < 45000 dollar167(39.86)20(33.90)147(40.83) 45000–100000 dollar172(41.05)27(45.76)145(40.28)0.595b0.678 > 100000 dollar80(19.09)12(20.34)68(18.89)Education (N, %) High school graduate or less153(36.51)19(32.20)134(37.22) College144(34.37)24(40.68)120(33.33)0.538b0.678 Graduate degree122(29.12)16(27.12)106(29.45)Smoke (N, %) Yes106(27.68)23(38.98)93(25.80) No303(72.32)36(61.02)267(74.72)0.036*b0.211aindependent-samples t-testbchi-square test*p < 0.05 Baseline characteristics of participants aindependent-samples t-test bchi-square test *p < 0.05 Comparison of cardiometabolic parameters and allostatic load between groups As is shown in Table 2, the infertility group exhibited significantly less favorable cardiometabolic profiles compared to controls. Specifically, infertility patients demonstrated: Greater AC: [101.10 (IQR: 117.20–86.60) cm vs. 92.30(IQR: 104.75–81.80) cm, P = 0.004]; Higher BMI: [33.90 (IQR: 39.00–24.60) kg/m2 vs. 27.85(IQR: 33.50–23.4) kg/m2, P = 0.002]; Elevated SBP: 115.75 ± 13.76 mmHg vs. 112.34 ± 11.70 mmHg (P = 0.044); Reduced HDL: 50.93 ± 13.11 mg/dL vs. 57.27 ± 15.65 mg/dL (P = 0.003), after weighting, the differences between the two groups in AC, BMI, and HDL remained statistically significant (P = 0.021,0.035,0.024. respectively). The allostatic load score was significantly higher in infertile women compared to controls [3.00 (IQR: 4.50–1.00) vs. 2.00 (IQR: 3.00–0.00), P = 0.011], after weighting, the difference between the two groups remained statistically significant (P = 0.029). While DBP, HOMA-IR, TG, LDL-C, and hs-CRP showed slight elevations in the infertility group, these differences did not reach statistical significance (all P > 0.05). Collectively, these physiological alterations contribute to the observed increase in allostatic load among infertile women. Table 2Comparison of Allostatic index between two groupsBiomarkersInfertility group (n = 59)Control group (n = 360)P-valueWeighted p-valueDBP(x ± s, mmHg)69.91 ± 10.4768.76 ± 9.830.409a0.490SBP(x ± s, mmHg)115.75 ± 13.76112.34 ± 11.700.044*a0.105BMI, median (IQR)kg/m233.90 (39.00,24.60)27.85 (33.50,23.40)0.002**b0.035AC, median (IQR)cm101.10 (117.20,86.60)92.30 (104.75,81.80)0.004**b0.021HOMA-IR, median (IQR)2.57 (3.92,1.57)2.21 (3.99,1.33)0.25b0.444TG,median (IQR)mg/dl72 (101,55)68 (109.00,49.00)0.531b0.871LDL(x ± s, mg/dl)109.03 ± 32.05103.51 ± 28.490.176a0.739HDL(x ± s, mg/dl)50.93 ± 13.1157.27 ± 15.650.003**a0.024Hs-CRP, median (IQR)mg/L3.10 (6.51,1.00)2.10 (5.09,0.75)0.123b0.810Allostatic index point3.00 (4.50,1.00)2.00 (3.00,0.00)0.011*b0.029aindependent-samples t-testbMann–Whitney U test*p < 0.05**p < 0.005 Table 2Comparison of Allostatic index between two groupsBiomarkersInfertility group (n = 59)Control group (n = 360)P-valueWeighted p-valueDBP(x ± s, mmHg)69.91 ± 10.4768.76 ± 9.830.409a0.490SBP(x ± s, mmHg)115.75 ± 13.76112.34 ± 11.700.044*a0.105BMI, median (IQR)kg/m233.90 (39.00,24.60)27.85 (33.50,23.40)0.002**b0.035AC, median (IQR)cm101.10 (117.20,86.60)92.30 (104.75,81.80)0.004**b0.021HOMA-IR, median (IQR)2.57 (3.92,1.57)2.21 (3.99,1.33)0.25b0.444TG,median (IQR)mg/dl72 (101,55)68 (109.00,49.00)0.531b0.871LDL(x ± s, mg/dl)109.03 ± 32.05103.51 ± 28.490.176a0.739HDL(x ± s, mg/dl)50.93 ± 13.1157.27 ± 15.650.003**a0.024Hs-CRP, median (IQR)mg/L3.10 (6.51,1.00)2.10 (5.09,0.75)0.123b0.810Allostatic index point3.00 (4.50,1.00)2.00 (3.00,0.00)0.011*b0.029aindependent-samples t-testbMann–Whitney U test*p < 0.05**p < 0.005 Comparison of Allostatic index between two groups aindependent-samples t-test bMann–Whitney U test *p < 0.05 **p < 0.005 Association between allostatic load index and infertility As summarized in Table 3, we observed a significant positive association between higher allostatic load index scores and increased infertility risk across all three adjusted models. The odds ratios (95% confidence intervals) were: Model 1: 1.153 (1.026–1.296), Model 2: 1.150 (1.017–1.301), Model 3: 1.151 (1.018–1.301) (all P < 0.05). Notably, serum HDL levels demonstrated a significant negative association with infertility in the fully adjusted Model 3 (Fig. 2). Table 3Odds ratio (95% confidence interval) of the relationship between infertility and allostatic load, NHANES 2015–2018Model 1 (OR 95% CI)PModel 2 (OR 95% CI)PModel 3 (OR 95% CI)PAL point1.153 (1.026,1.296)0.017*1.150 (1.017,1.301)0.026*1.151 (1.018,1.301)0.025*HDL0.962 (0.937,0.989)0.005*0.958 (0.932,0.985)0.003**0.958 (0.931,0.985)0.003**BMI0.997 (0.915,1.087)0.9520.990 (0.904,1.084)0.8290.996 (0.909,1.091)0.928AC1.016 (0.977,1.056)0.4081.018 (0.976,1.062)0.4041.013 (0.971,1.056)0.559SBP1.017 (0.986,1.049)0.2561.021 (0.989,1.054)0.1951.018 (0.986,1.052)0.273LDL1.007 (0.997,1.017)0.1831.006 (0.996,1.017)0.2371.007 (0.996,1.017)0.225TG0.992 (0.985,0.999)0.029*0.992 (0.985,0.999)0.017*0.991 (0.983,0.998)0.017*DBP0.998 (0.962,1.035)0.9980.991 (0.953,1.030)0.6320.994 (0.956,1.033)0.762HsCRP0.986 (0.932,1.043)0.6170.985 (0.929,1.046)0.6240.989 (0.932,1.050)0.726HOMA-IR0.977 (0.910,01.050)0.5280.984 (0.916,1.057)0.6640.988 (0.920,1.061)0.739*p<0.05 ** p< 0.005 Fig. 2The odd ratios of relationship between biomarkers and infertility Table 3Odds ratio (95% confidence interval) of the relationship between infertility and allostatic load, NHANES 2015–2018Model 1 (OR 95% CI)PModel 2 (OR 95% CI)PModel 3 (OR 95% CI)PAL point1.153 (1.026,1.296)0.017*1.150 (1.017,1.301)0.026*1.151 (1.018,1.301)0.025*HDL0.962 (0.937,0.989)0.005*0.958 (0.932,0.985)0.003**0.958 (0.931,0.985)0.003**BMI0.997 (0.915,1.087)0.9520.990 (0.904,1.084)0.8290.996 (0.909,1.091)0.928AC1.016 (0.977,1.056)0.4081.018 (0.976,1.062)0.4041.013 (0.971,1.056)0.559SBP1.017 (0.986,1.049)0.2561.021 (0.989,1.054)0.1951.018 (0.986,1.052)0.273LDL1.007 (0.997,1.017)0.1831.006 (0.996,1.017)0.2371.007 (0.996,1.017)0.225TG0.992 (0.985,0.999)0.029*0.992 (0.985,0.999)0.017*0.991 (0.983,0.998)0.017*DBP0.998 (0.962,1.035)0.9980.991 (0.953,1.030)0.6320.994 (0.956,1.033)0.762HsCRP0.986 (0.932,1.043)0.6170.985 (0.929,1.046)0.6240.989 (0.932,1.050)0.726HOMA-IR0.977 (0.910,01.050)0.5280.984 (0.916,1.057)0.6640.988 (0.920,1.061)0.739*p<0.05 ** p< 0.005 Odds ratio (95% confidence interval) of the relationship between infertility and allostatic load, NHANES 2015–2018 *p<0.05 ** p< 0.005 The odd ratios of relationship between biomarkers and infertility Factor analysis identified BMI, LDL, TG, HDL, and hs-CRP as key contributors to allostatic load in infertile women (Table 4). Table 4Factor contribution of the components of allostatic load in patients with infertilityInfertilityControlDBP0.050.16SBP0.070.01BMI0.360.37AC0.020.07HOMA-IR0.010.08Triglyceride0.140.13LDL0.160.10HDL0.090.05HsCRP0.080.04 Table 4Factor contribution of the components of allostatic load in patients with infertilityInfertilityControlDBP0.050.16SBP0.070.01BMI0.360.37AC0.020.07HOMA-IR0.010.08Triglyceride0.140.13LDL0.160.10HDL0.090.05HsCRP0.080.04 Factor contribution of the components of allostatic load in patients with infertility Subgroup analysis As shown in Fig. 3, the ALS demonstrated a more pronounced association with infertility risk among non-smoking women compared to their smoking counterparts (OR [95% CI] 1.180 [1.006–1.385] vs. 1.088 [0.892–1.326], respectively).Fig. 3Subgroup analysis of the relationship between AL and infertility Subgroup analysis of the relationship between AL and infertility Discussion Allostatic load, as widely recognized in the scientific literature, serves as a quantitative measure of the physiological consequences associated with chronic and multisystem stress adaptation [9], characterized by the cumulative burden of chronic stress and adverse life events, it reflects dysregulated interactions across neuroendocrine, immune, metabolic, and cardiovascular systems. This physiological state emerges when adaptive allostatic mechanisms either become chronically overactivated or fail to appropriately terminate the stress responses [8, 12]. Chronic stress primarily activates the SNS and HPA axis, leading to catecholamine and cortisol release. These stress mediators subsequently induce multi-system dysregulation, characterized by cardiovascular hyperactivity (elevated HR, SBP, DBP), metabolic disturbances (hyperglycemia, dyslipidemia with increased LDL and decreased HDL), increased inflammatory markers (hsCRP, IL-6), and anthropometric changes (altered BMI and waist-to-hip ratio) [13], thus leading to the development of diseases. Epidemiological evidence has consistently demonstrated a significant association between chronic stress exposure and impaired fertility outcomes, and targeted psychological interventions for women experiencing infertility have been shown to significantly improve subsequent pregnancy rates [14]. As systematically reviewed by Edwards et al., chronic stress exerts detrimental effects on the hypothalamic–pituitary–adrenal (HPA) axis, leading to dysregulated secretion of key reproductive hormones including gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH). This neuroendocrine disruption subsequently interferes with uterine development and ovarian follicular maturation, ultimately compromising female reproductive function through impaired ovulatory processes [15].A population-based fertility study conducted among Chinese women demonstrated a significant inverse association between ALS and fertility potential, suggesting that women exhibiting higher ALS levels may demonstrate reduced reproductive capacity [10], which aligns with our current observations, although the biomarker panels differed substantially and the previous study did not identify optimal predictive indicators for ALS. Conversely, another investigation reported that ALS exerted no significant influence on fertility outcomes specifically among women undergoing ART for unexplained infertility [9]. This study investigates the association between allostatic load and infertility using data from the NHANES 2015–2018 cycle. Our findings reveal a significant positive association between elevated allostatic load scores and infertility risk, indicating that higher allostatic load levels are associated with the onset of infertility. Through principal component factor analysis, we identified BMI, LDL, TG, HDL, and hs-CRP as the most discriminative biomarkers for predicting allostatic load in infertile women, reveals the dysfunctions of the metabolic system and immune system are associated with the occurrence of infertility. In our multivariable-adjusted analysis (Model 3), each one-unit increase in allostatic load score was associated with a 15.1% (95% CI [1.018–1.301]) higher risk of infertility, with this association demonstrating consistency across all three models, higher educational attainment and annual household income were unexpectedly associated with increased infertility risk. Consistent with prior research [16, 17], we find that infertile women had higher smoking exposure (P = 0.036), although the differences between the two groups were not significant after weighting (P = 0.211), it may be caused by limited samples for the infertility group. According to subgroup analysis, we find a more stronger association between non-smoke infertile women and ALS (OR 1.180, 95% CI 1.006–3.385).This association may be attributed to increased smoking behavior resulting from long-term chronic stress [18]. In Table 3 of the manuscript, we demonstrate the protective effects of elevated HDL and TG levels against infertility, and he post hoc power analysis yielded a statistical power (1-β) of 94% in HDL. As previously reported, dyslipidemia-induced pathological conditions can disrupt multiple critical aspects of fertility—including oocyte development, ovulation, oocyte quality, and endometrial receptivity—thereby impairing pregnancy. Elevated HDL levels modulate these dyslipidemic abnormalities, consequently improving infertility outcomes [19, 20]. In contrast, the marginal protective effect of TG is more likely attributable to asymmetrical sample distribution between groups and metabolic intercorrelations, necessitating further validation. Currently, limited research has investigated the association between ALS and female fertility, particularly with regard to disease subtypes and potential interactions. Our study revealed that the association of ALS on fertility is more pronounced in non-smoking women compared to smokers. This group may have fewer resources to cope with life stressors and chronic stress, potentially leading to increased physiological strain across multiple systems as they strive to maintain health and homeostasis. Beyond its effects on fertility, ALS is also associated with adverse pregnancy outcomes, including preterm birth, low birth weight, and eclampsia [9]. Hence, recognizing the allostatic load in women of reproductive age constitutes a critical consideration. To our knowledge, this is the first study to investigate the association between ALS and infertility using a large, representative sample of the U.S. population. The data for this analysis were derived from the NHANES, a nationally representative dataset characterized by rigorous quality control protocols and high-quality clinical variables meticulously collected by trained personnel. These methodological strengths enhance the reliability and validity of our findings. However, these findings should be interpreted cautiously due to several limitations. Firstly, the relatively small sample size is relatively small, and we conduct the post hoc power analysis, revealed an estimated statistical power (1-β) of approximately 60% (at α = 0.05) in most individual variables, which is below the commonly recommended threshold of 80%, implies reduced sensitivity to detect modest effects, particularly for non-significant outcomes, highlights the need for replication in adequately powered studies. The post hoc power analysis yielded a statistical power (1-β) of 94% in HDL, indicating a high likelihood of detecting a true effect. Secondly, potential confounding factors—including biomarker selection, the methodology for ALS calculation, and the absence of temporal sequencing—could influence the results. Most importantly, the cross-sectional design precludes establishing causal relationships. Consequently, well-powered prospective studies with robust methodologies are warranted to elucidate this association definitively.